| A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ... European urology 72 (5), 665-674, 2017 | 172 | 2017 |
| Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, MA Bilen, V Santos, J Esther, ... Cancer 126 (6), 1208-1216, 2020 | 76 | 2020 |
| Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial J Murgic, G Morton, A Loblaw, L D'Alimonte, A Ravi, M Wronski, ... International Journal of Radiation Oncology* Biology* Physics 102 (3), 561-567, 2018 | 59 | 2018 |
| Tumor-absorbed dose predicts progression-free survival following 131I-tositumomab radioimmunotherapy YK Dewaraja, MJ Schipper, J Shen, LB Smith, J Murgic, H Savas, ... Journal of Nuclear Medicine 55 (7), 1047-1053, 2014 | 53 | 2014 |
| Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ... European urology 72 (1), 22-31, 2017 | 51 | 2017 |
| Genomic classifier for guiding treatment of intermediate-risk prostate cancers to dose-escalated image guided radiation therapy without hormone therapy A Berlin, J Murgic, A Hosni, M Pintilie, A Salcedo, M Fraser, S Kamel-Reid, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 84-91, 2019 | 49 | 2019 |
| A new prognostic model in patients with advanced urothelial carcinoma treated with first-line immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, ... European urology oncology 4 (3), 464-472, 2021 | 45 | 2021 |
| Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy D Kust, M Prpić, J Murgić, M Jazvić, B Jakšić, D Krilić, A Bolanča, Z Kusić Anticancer Research 34 (6), 3177-3184, 2014 | 44 | 2014 |
| Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer J Murgic, P Chung, A Berlin, A Bayley, P Warde, C Catton, A Simeonov, ... Brachytherapy 15 (2), 147-155, 2016 | 37 | 2016 |
| Histological subtypes and response to PD-1/PD-L1 blockade in advanced urothelial cancer: a retrospective study NJ Miller, AR Khaki, LN Diamantopoulos, MA Bilen, V Santos, N Agarwal, ... The Journal of urology 204 (1), 63-70, 2020 | 36 | 2020 |
| Breast and gynecological cancers in Croatia, 1988-2008 I Kelava, K Tomičić, M Kokić, A Ćorušić, P Planinić, I Kirac, J Murgić, ... Croatian medical journal 53 (2), 100-108, 2012 | 36 | 2012 |
| Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy H Raziee, FY Moraes, J Murgic, MLK Chua, M Pintilie, P Chung, ... Radiotherapy and Oncology 123 (3), 459-465, 2017 | 23 | 2017 |
| Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes SM Esagian, AR Khaki, LN Diamantopoulos, L Carril‐Ajuria, D Castellano, ... BJU international 128 (2), 196-205, 2021 | 21 | 2021 |
| The ageing of Croatian population J Murgić, T Jukić, S Tomek-Roksandić, M Ljubičić, Z Kusić Collegium antropologicum 33 (2), 701-705, 2009 | 19 | 2009 |
| Oncologist burnout syndrome in Eastern Europe: results of the multinational survey D Kust, J Murgic, P Vukovic, I Kruljac, M Prpic, A Zilic, C Lengyel, ... JCO Oncology Practice 16 (4), e366-e376, 2020 | 18 | 2020 |
| Determining the impact of spatial heterogeneity on genomic prognostic biomarkers for localized prostate cancer HC Brastianos, J Murgic, A Salcedo, MLK Chua, A Meng, M Fraser, ... European Urology Oncology 5 (3), 362-365, 2022 | 15 | 2022 |
| Time to nadir PSA: of popes and PSA—the immortality bias SB Johnson, WC Jackson, J Murgic, FY Feng, DA Hamstra American Journal of Clinical Oncology 38 (5), 465-471, 2015 | 15 | 2015 |
| Quality of life of Croatian breast cancer patients receiving adjuvant treatment–comparison to long-term breast cancer survivors J Murgic, Z Soldic, D Vrljic, I Samija, I Kirac, A Bolanca, Z Kusic Collegium antropologicum 36 (4), 1335-1341, 2012 | 14 | 2012 |
| Sunitinib-induced thyrotoxicosis–a not so rare entity M Jazvić, M Prpić, T Jukić, J Murgić, B Jakšić, D Kust, A Prgomet, ... Anticancer research 35 (1), 481-485, 2015 | 13 | 2015 |
| Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature Ž Soldić, J Murgić, J Radić, N Dabelić, M Jazvić, J Marić Brozić, Z Kusić Collegium antropologicum 35 (2), 611-614, 2011 | 12 | 2011 |
Marin PrpicAssistant professor, M.D., Ph.D., University of Zagreb School of Dental MedicineVerified email at sfzg.unizg.hr
